Trial · NCT01358721
Results by group144
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 144
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Percent Change From Baseline in Activated and Memory T Cells | Nivolumab 0.3 mg/kg (Previously-treated) | Cycle 1 Day 1 | NA | 95% Confidence Interval NA to NA | Percentage |
| Percent Change From Baseline in Activated and Memory T Cells | Nivolumab 2 mg/kg (Previously-treated) | Cycle 1 Day 1 | NA | 95% Confidence Interval NA to NA | Percentage |
| Percent Change From Baseline in Activated and Memory T Cells | Nivolumab 10 mg/kg (Previously-treated) | Cycle 1 Day 1 | NA | 95% Confidence Interval NA to NA | Percentage |
| Percent Change From Baseline in Activated and Memory T Cells | Nivolumab 10 mg/kg (Treatment-naive) | Cycle 1 Day 1 | NA | 95% Confidence Interval NA to NA | Percentage |
| Percent Change From Baseline in Activated and Memory T Cells | Nivolumab 0.3 mg/kg (Previously-treated) | Cycle 1 Day 2 | NA | 95% Confidence Interval NA to NA | Percentage |
| Percent Change From Baseline in Activated and Memory T Cells | Nivolumab 2 mg/kg (Previously-treated) | Cycle 1 Day 2 | NA | 95% Confidence Interval NA to NA | Percentage |
| Percent Change From Baseline in Activated and Memory T Cells | Nivolumab 10 mg/kg (Previously-treated) | Cycle 1 Day 2 | NA | 95% Confidence Interval NA to NA | Percentage |
| Percent Change From Baseline in Activated and Memory T Cells | Nivolumab 10 mg/kg (Treatment-naive) | Cycle 1 Day 2 | NA | 95% Confidence Interval NA to NA | Percentage |
| Percent Change From Baseline in Activated and Memory T Cells | Nivolumab 0.3 mg/kg (Previously-treated) | Cycle 1 Day 8 | NA | 95% Confidence Interval NA to NA | Percentage |
| Percent Change From Baseline in Activated and Memory T Cells | Nivolumab 2 mg/kg (Previously-treated) | Cycle 1 Day 8 | NA | 95% Confidence Interval NA to NA | Percentage |
| Percent Change From Baseline in Activated and Memory T Cells | Nivolumab 10 mg/kg (Previously-treated) | Cycle 1 Day 8 | NA | 95% Confidence Interval NA to NA | Percentage |
| Percent Change From Baseline in Activated and Memory T Cells | Nivolumab 10 mg/kg (Treatment-naive) | Cycle 1 Day 8 | NA | 95% Confidence Interval NA to NA | Percentage |
| Percent Change From Baseline in Activated and Memory T Cells | Nivolumab 0.3 mg/kg (Previously-treated) | Cycle 2 Day 8 | NA | 95% Confidence Interval NA to NA | Percentage |
| Percent Change From Baseline in Activated and Memory T Cells | Nivolumab 2 mg/kg (Previously-treated) | Cycle 2 Day 8 | NA | 95% Confidence Interval NA to NA | Percentage |
| Percent Change From Baseline in Activated and Memory T Cells | Nivolumab 10 mg/kg (Previously-treated) | Cycle 2 Day 8 | NA | 95% Confidence Interval NA to NA | Percentage |
| Percent Change From Baseline in Activated and Memory T Cells | Nivolumab 10 mg/kg (Treatment-naive) | Cycle 2 Day 8 | NA | 95% Confidence Interval NA to NA | Percentage |
| Percent Change From Baseline in Activated and Memory T Cells | Nivolumab 0.3 mg/kg (Previously-treated) | Cycle 4 Day 1 | NA | 95% Confidence Interval NA to NA | Percentage |
| Percent Change From Baseline in Activated and Memory T Cells | Nivolumab 2 mg/kg (Previously-treated) | Cycle 4 Day 1 | NA | 95% Confidence Interval NA to NA | Percentage |
| Percent Change From Baseline in Activated and Memory T Cells | Nivolumab 10 mg/kg (Previously-treated) | Cycle 4 Day 1 | NA | 95% Confidence Interval NA to NA | Percentage |
| Percent Change From Baseline in Activated and Memory T Cells | Nivolumab 10 mg/kg (Treatment-naive) | Cycle 4 Day 1 | NA | 95% Confidence Interval NA to NA | Percentage |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01358721/results